The influence of American public health researcher Dr Lisa Littman, best known for coining the term “rapid-onset gender dysphoria” (ROGD), appears to have been unaffected by activist attacks on her work.
In its February 25 statement, the French National Academy of Medicine cites Dr Littman’s ROGD paper in the context of “a sharp increase in demand for medical interventions” to treat youth gender dysphoria.
Also last month, Sweden’s National Board of Health and Welfare referenced Dr Littman’s 2021 detransitioners study and declared that the low regret rate (often lower than 1 per cent) claimed by youth gender clinics “no longer stands unchallenged”.
In the Littman detransitioner study, only 24 per cent of the 100-strong sample said they went back to their gender clinic to report their regret.
Thursday’s interim report from the United Kingdom’s official review of the Tavistock youth gender clinic also cites Dr Littman’s detransitioners paper.
The independent review of youth gender dysphoria care within the National Health Service is led by Dr Hilary Cass, who is a former president of the Royal College of Paediatrics and Child Health, with a track record of concern about patient safety.
“The issues faced by detransitioners highlight the need for better services and pathways for this group, many of whom are living with irreversible effects of transition but for whom there is no clear access to services as they fall outside the responsibility of NHS gender identity services,” the report says.
Tomorrow the international parents’ group Genspect is hosting a #DetransAwarenessDay forum featuring well-known detransitioners including Sinéad Watson, Helena Kerschner, Grace Lidinsky-Smith, and Keira Bell, whose litigation against the Tavistock clinic has been big news around the world.
Skip to content